October 13, 2016
(Washington, D.C.)— Amid the debate on escalating drug prices, a new report estimates that by implementing the full range of...
October 13, 2016
(Washington, D.C.)— Amid the debate on escalating drug prices, a new report estimates that by implementing the full range of...
PCMA Statement on Oversight Committee Hearing on EpiPen Price Hikes
September 21, 2016
(Washington, D.C.) —Pharmaceutical Care Management Association (PCMA) President and CEO Mark Merritt issued the following statement on today’s House Committee...
September 20, 2016
A new report, “Comparison of Hepatitis C Treatment Costs,” shows Hepatitis C drug prices, specifically negotiated by pharmacy benefit managers...